Organization of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells

被引:27
作者
Chaly, N [1 ]
Chen, X [1 ]
Dentry, J [1 ]
Brown, DL [1 ]
机构
[1] UNIV OTTAWA,DEPT BIOL,OTTAWA,ON,CANADA
关键词
cell cycle; HeLa; immunolocalization; lymphocytes; Topo II isotypes;
D O I
10.1007/BF02265053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have monitored the organization of DNA topoisomerase II (Topo II) in relation to chromatin disaggregation during mitogen stimulation of lymphocytes and to the mitotic chromosome condensation cycle by immunofluorescence microscopy with isozyme-specific antibodies. Labelling for both Topo II alpha and Topo II beta was diffusely nucleoplasmic and non-nucleolar in resting lymphocytes and the pattern changed little during stimulation. Topo II alpha labelling intensity increased in parallel with the extent of cell stimulation, but a fraction of fully stimulated cells was labelled very brightly. Topo II beta labelling intensity was also greater in stimulated cells, but all partially and fully stimulated cells were labelled at the same, higher, intensity. In addition, anti-Topo II beta detected a few small spots within nucleoli of stimulated cells that coincided with regions containing fibrillarin. In lymphocytes and HeLa, chromosome association of Topo II alpha began in prophase and lasted throughout mitosis. In contrast, Topo II beta stayed nucleoplasmic in prophase, was diffusely cytoplasmic during mitosis, and was first detected post-mitotically in nuclei with decondensing chromosomes and a reformed nuclear envelope. The results are consistent with a role for Topo II alpha, but not for Topo II beta, in mitotic chromosome condensation, and indicate that the isotypes may play independent roles in the reorganization of chromatin structure during lymphocyte mitogenic activation.
引用
收藏
页码:457 / 466
页数:10
相关论文
共 37 条
[1]  
AZUMGELADE MC, 1994, J CELL SCI, V107, P463
[2]   INSITU LOCALIZATION OF DNA TOPOISOMERASE-II, A MAJOR POLYPEPTIDE COMPONENT OF THE DROSOPHILA NUCLEAR MATRIX-FRACTION [J].
BERRIOS, M ;
OSHEROFF, N ;
FISHER, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) :4142-4146
[3]  
BROWN DL, 1990, BIOCH STRUCTURAL DYN, P161
[4]  
CHALY N, 1988, BIOL CELL, V63, P9
[5]   ASSEMBLY OF ADENOVIRUS-SPECIFIC NUCLEAR INCLUSIONS IN LYTICALLY INFECTED HELA-CELLS - AN ULTRASTRUCTURAL AND CYTOCHEMICAL STUDY [J].
CHALY, N ;
CHEN, X .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1993, 71 (9-10) :475-487
[6]   CHANGES IN DISTRIBUTION OF NUCLEAR MATRIX ANTIGENS DURING THE MITOTIC CELL-CYCLE [J].
CHALY, N ;
BLADON, T ;
SETTERFIELD, G ;
LITTLE, JE ;
KAPLAN, JG ;
BROWN, DL .
JOURNAL OF CELL BIOLOGY, 1984, 99 (02) :661-671
[7]  
CHALY N, 1996, IN PRESS J CELL BIOC
[8]   CHARACTERIZATION AND IMMUNOLOGICAL IDENTIFICATION OF CDNA CLONES ENCODING 2 HUMAN DNA TOPOISOMERASE-II ISOZYMES [J].
CHUNG, TDY ;
DRAKE, FH ;
TAN, KB ;
PER, SR ;
CROOKE, ST ;
MIRABELLI, CK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9431-9435
[9]   ROLE OF TOPOISOMERASE-II IN THE STRUCTURAL AND FUNCTIONAL EVOLUTION OF MITOGEN-STIMULATED LYMPHOCYTE NUCLEI [J].
DAEV, E ;
CHALY, N ;
BROWN, DL ;
VALENTINE, B ;
LITTLE, JE ;
CHEN, X ;
WALKER, PR .
EXPERIMENTAL CELL RESEARCH, 1994, 214 (01) :331-342
[10]   BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF P170 AND P180 FORMS OF TOPOISOMERASE-II [J].
DRAKE, FH ;
HOFMANN, GA ;
BARTUS, HF ;
MATTERN, MR ;
CROOKE, ST ;
MIRABELLI, CK .
BIOCHEMISTRY, 1989, 28 (20) :8154-8160